Status:
COMPLETED
Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Penn State University
University of Manchester
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Meta Cognitive Therapy (MCT) has been introduced as a new specific treatment for generalised anxiety disorder. So far, no studies have examined CBT and MCT in comparison with each other in a randomise...
Eligibility Criteria
Inclusion
- Signed written informed consent obtained prior to entry in the study.
- Diagnosed with generalised anxiety disorder (DSM-IV, APA, 1994).
- 18 years or older.
Exclusion
- Known somatic diseases
- Psychosis
- Past suicidal attempts and/or current intent
- PTSD
- Cluster A or cluster B personality disorder
- Substance dependence
- Not willing to accept random allocation.
- Patients not willing to withdraw psychotropic medication for a period of 4 weeks prior to entry to the trial
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT00426426
Start Date
January 1 2007
End Date
December 1 2015
Last Update
October 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Psychology, Norwegian University of Science and Technology
Trondheim, Norway, N-7491